Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoltan Matrai

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Cancers|April 3, 2021
Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA StudyMaggie Banys-Paluchowski, Maria Luisa Gasparri, Jana de Boniface, et al.
Annals of Surgical Oncology|October 14, 2021
Retrospective, Multicenter Analysis Comparing Conventional with Oncoplastic Breast Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 StudyFlorian Fitzal, Michael Bolliger, Daniela Dunkler, et al.
BMJ Open|September 3, 2021
Prepectoral versus subpectoral implant-based breast reconstruction after skin-sparing mastectomy or nipple-sparing mastectomy (OPBC-02/ PREPEC): a pragmatic, multicentre, randomised, superiority trialElisabeth A Kappos, Alexandra Schulz, Meredith M Regan, et al.
Cancer Treatment Reviews|May 1, 2023
Uncertainties and controversies in axillary management of patients with breast cancerWalter P Weber, Oreste Davide Gentilini, Monica Morrow, et al.
JAMA Surgery|July 19, 2023
Association of Axillary Dissection With Systemic Therapy in Patients With Clinically Node-Positive Breast CancerWalter P Weber, Zoltan Matrai, Stefanie Hayoz, et al.
Breast (Edinburgh, Scotland)|September 23, 2021
Tailored axillary surgery in patients with clinically node-positive breast cancer: Pre-planned feasibility substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)Walter P Weber, Zoltan Matrai, Stefanie Hayoz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2026
Marking Techniques for Target Lymph Nodes in Node-Positive Breast Cancer Treated With Neoadjuvant Therapy in the AXSANA/EUBREAST-03/AGO-B-053 StudyMaggie Banys-Paluchowski, Steffi Hartmann, Jana de Boniface, et al.
Breast Cancer Research and Treatment|September 6, 2018
Oncoplastic Breast Consortium consensus conference on nipple-sparing mastectomyWalter P Weber, Martin Haug, Christian Kurzeder, et al.
Breast Cancer Research and Treatment|June 24, 2023
Trends in use of neoadjuvant systemic therapy in patients with clinically node-positive breast cancer in Europe: prospective TAXIS study (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)Christoph Tausch, Kavitha Däster, Stefanie Hayoz, et al.
Journal of the National Cancer Institute|July 28, 2021
Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk ScoresDaniel R Barnes, Valentina Silvestri, Goska Leslie, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Cancers|April 3, 2021
Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA StudyMaggie Banys-Paluchowski, Maria Luisa Gasparri, Jana de Boniface, et al.
Annals of Surgical Oncology|October 14, 2021
Retrospective, Multicenter Analysis Comparing Conventional with Oncoplastic Breast Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 StudyFlorian Fitzal, Michael Bolliger, Daniela Dunkler, et al.
BMJ Open|September 3, 2021
Prepectoral versus subpectoral implant-based breast reconstruction after skin-sparing mastectomy or nipple-sparing mastectomy (OPBC-02/ PREPEC): a pragmatic, multicentre, randomised, superiority trialElisabeth A Kappos, Alexandra Schulz, Meredith M Regan, et al.
Cancer Treatment Reviews|May 1, 2023
Uncertainties and controversies in axillary management of patients with breast cancerWalter P Weber, Oreste Davide Gentilini, Monica Morrow, et al.
JAMA Surgery|July 19, 2023
Association of Axillary Dissection With Systemic Therapy in Patients With Clinically Node-Positive Breast CancerWalter P Weber, Zoltan Matrai, Stefanie Hayoz, et al.
Breast (Edinburgh, Scotland)|September 23, 2021
Tailored axillary surgery in patients with clinically node-positive breast cancer: Pre-planned feasibility substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)Walter P Weber, Zoltan Matrai, Stefanie Hayoz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2026
Marking Techniques for Target Lymph Nodes in Node-Positive Breast Cancer Treated With Neoadjuvant Therapy in the AXSANA/EUBREAST-03/AGO-B-053 StudyMaggie Banys-Paluchowski, Steffi Hartmann, Jana de Boniface, et al.
Breast Cancer Research and Treatment|September 6, 2018
Oncoplastic Breast Consortium consensus conference on nipple-sparing mastectomyWalter P Weber, Martin Haug, Christian Kurzeder, et al.
Breast Cancer Research and Treatment|June 24, 2023
Trends in use of neoadjuvant systemic therapy in patients with clinically node-positive breast cancer in Europe: prospective TAXIS study (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)Christoph Tausch, Kavitha Däster, Stefanie Hayoz, et al.
Journal of the National Cancer Institute|July 28, 2021
Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk ScoresDaniel R Barnes, Valentina Silvestri, Goska Leslie, et al.
Pageof 3